1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Human Microbiome Market, By Product
5.1 Introduction
5.2 Medical Foods
5.3 Prebiotics
5.4 Probiotics
5.5 Symboitics
5.6 Other Products
6 Global Human Microbiome Market, By Disease
6.1 Introduction
6.2 Metabolic
6.3 Endocrine
6.4 Infectious
7 Global Human Microbiome Market, By Type
7.1 Introduction
7.2 Cancer
7.3 Metabolic and Gastrointestinal Disorders
7.4 Autoimmune Disorder
7.5 Obesity
7.6 Other Types
8 Global Human Microbiome Market, By Application
8.1 Introduction
8.2 Diagnostics
8.3 Therapeutics
8.4 Other Applications
9 Global Human Microbiome Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Seres Therapeutics
11.2 Second Genome Inc.
11.3 Osel Inc.
11.4 Exeliom Biosciences SAS
11.5 Ginkgo Bioworks
11.6 Finch Therapeutics Group Inc.
11.7 Evelo Biosciences Inc
11.8 DuPont
11.9 Axial Biotherapeutics, Inc.
11.10 Astarte Medical
List of Tables
Table 1 Global Human Microbiome Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 4 Global Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 5 Global Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 6 Global Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 7 Global Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 8 Global Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 9 Global Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 10 Global Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 11 Global Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 12 Global Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 13 Global Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 14 Global Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 15 Global Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 16 Global Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 17 Global Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 18 Global Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 19 Global Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 20 Global Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 21 Global Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 22 North America Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 23 North America Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 24 North America Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 25 North America Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 26 North America Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 27 North America Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 28 North America Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 29 North America Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 30 North America Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 31 North America Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 32 North America Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 33 North America Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 34 North America Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 35 North America Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 36 North America Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 37 North America Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 38 North America Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 39 North America Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 40 North America Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 41 North America Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 42 North America Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 43 Europe Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 44 Europe Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 45 Europe Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 46 Europe Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 47 Europe Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 48 Europe Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 49 Europe Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 50 Europe Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 51 Europe Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 52 Europe Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 53 Europe Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 54 Europe Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 55 Europe Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 56 Europe Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 57 Europe Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 58 Europe Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 59 Europe Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 60 Europe Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 61 Europe Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 62 Europe Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 63 Europe Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 64 Asia Pacific Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 65 Asia Pacific Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 66 Asia Pacific Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 67 Asia Pacific Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 68 Asia Pacific Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 69 Asia Pacific Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 70 Asia Pacific Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 71 Asia Pacific Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 72 Asia Pacific Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 73 Asia Pacific Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 74 Asia Pacific Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 75 Asia Pacific Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 76 Asia Pacific Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 77 Asia Pacific Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 78 Asia Pacific Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 79 Asia Pacific Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 80 Asia Pacific Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 81 Asia Pacific Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 82 Asia Pacific Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 83 Asia Pacific Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 84 Asia Pacific Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 85 South America Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 86 South America Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 87 South America Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 88 South America Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 89 South America Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 90 South America Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 91 South America Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 92 South America Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 93 South America Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 94 South America Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 95 South America Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 96 South America Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 97 South America Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 98 South America Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 99 South America Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 100 South America Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 101 South America Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 102 South America Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 103 South America Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 104 South America Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 105 South America Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
Table 106 Middle East & Africa Human Microbiome Market Outlook, By Country (2021-2030) ($MN)
Table 107 Middle East & Africa Human Microbiome Market Outlook, By Product (2021-2030) ($MN)
Table 108 Middle East & Africa Human Microbiome Market Outlook, By Medical Foods (2021-2030) ($MN)
Table 109 Middle East & Africa Human Microbiome Market Outlook, By Prebiotics (2021-2030) ($MN)
Table 110 Middle East & Africa Human Microbiome Market Outlook, By Probiotics (2021-2030) ($MN)
Table 111 Middle East & Africa Human Microbiome Market Outlook, By Symboitics (2021-2030) ($MN)
Table 112 Middle East & Africa Human Microbiome Market Outlook, By Other Products (2021-2030) ($MN)
Table 113 Middle East & Africa Human Microbiome Market Outlook, By Disease (2021-2030) ($MN)
Table 114 Middle East & Africa Human Microbiome Market Outlook, By Metabolic (2021-2030) ($MN)
Table 115 Middle East & Africa Human Microbiome Market Outlook, By Endocrine (2021-2030) ($MN)
Table 116 Middle East & Africa Human Microbiome Market Outlook, By Infectious (2021-2030) ($MN)
Table 117 Middle East & Africa Human Microbiome Market Outlook, By Type (2021-2030) ($MN)
Table 118 Middle East & Africa Human Microbiome Market Outlook, By Cancer (2021-2030) ($MN)
Table 119 Middle East & Africa Human Microbiome Market Outlook, By Metabolic and Gastrointestinal Disorders (2021-2030) ($MN)
Table 120 Middle East & Africa Human Microbiome Market Outlook, By Autoimmune Disorder (2021-2030) ($MN)
Table 121 Middle East & Africa Human Microbiome Market Outlook, By Obesity (2021-2030) ($MN)
Table 122 Middle East & Africa Human Microbiome Market Outlook, By Other Types (2021-2030) ($MN)
Table 123 Middle East & Africa Human Microbiome Market Outlook, By Application (2021-2030) ($MN)
Table 124 Middle East & Africa Human Microbiome Market Outlook, By Diagnostics (2021-2030) ($MN)
Table 125 Middle East & Africa Human Microbiome Market Outlook, By Therapeutics (2021-2030) ($MN)
Table 126 Middle East & Africa Human Microbiome Market Outlook, By Other Applications (2021-2030) ($MN)
| ※参考情報 ヒトマイクロバイオームとは、人間の体内や体表に存在する非常に多様な微生物群の総称です。これには細菌、真菌、ウイルス、原虫などが含まれます。ヒトマイクロバイオームは、体重の約1～2%に相当する数十兆個の細菌で構成されていますが、その遺伝子の数は人間の遺伝子の数をはるかに超えています。これらの微生物は、人間の健康や病気に大きな影響を与えることが知られています。 ヒトマイクロバイオームには、主に消化管、皮膚、口腔、鼻腔、膣などに存在する種類があります。特に消化管に生息する腸内細菌は、食物の消化や栄養素の吸収に重要な役割を果たしています。腸内細菌のバランスが崩れると、様々な健康問題が引き起こされることがあります。たとえば、肥満、糖尿病、炎症性腸疾患、アレルギー、自閉症などが指摘されています。 ヒトマイクロバイオームの研究は、主にメタゲノム解析やメタトランスクリプトーム解析などの先進的な技術を使用しています。これらの技術によって、微生物のDNAやRNAを網羅的に解析し、どの微生物がどのような機能を持っているかを理解することが可能になりました。また、次世代シーケンシング技術の進歩により、短期間で大量のデータを取得できるようになり、マイクロバイオームの多様性や変動の様子を明らかにすることができます。 ヒトマイクロバイオームの用途は広範です。医療分野では、マイクロバイオームのバランスを調整することで、さまざまな疾患の予防や治療が期待されています。プロバイオティクスやプレバイオティクスの使用がその一例です。プロバイオティクスは有益な微生物を含む食品やサプリメントであり、腸内環境を改善するために利用されます。一方、プレバイオティクスは、腸内の善玉菌の成長を促進する成分が含まれた食物です。 さらに、マイクロバイオームの研究は、個別化医療にも寄与する可能性があります。患者のマイクロバイオームの状態を分析し、個々に最適な治療法を提供することができるようになります。また、美容分野でも、スキンマイクロバイオームの研究が進められており、皮膚の健康を保つための製品開発に活用されています。 最近では、マイクロバイオームを用いた新しい治療法も注目されています。例えば、腸内フローラ移植（FMT）は、病気の治療において成功を収めている事例です。この治療法は、健康なドナーからの腸内細菌を患者に移植することで、悪化した腸内環境を改善し、疾患の症状を軽減します。 また、マイクロバイオームは、食事や生活習慣とも密接に関連していることが分かっています。食事の内容が微生物の構成に影響を与え、逆にマイクロバイオームが代謝に及ぼす影響が、健康や病気のリスクに直結することがあります。そのため、食事の見直しや生活習慣の改善が、マイクロバイオームの調整に効果的であると言われています。 今後の研究では、マイクロバイオームのさらなる解明が進み、疾患の予防や治療において新たなアプローチが期待されています。また、マイクロバイオームの特徴を定期的に測定し、健康管理に活用するためのパーソナライズドなサービスや商品も市場に登場する可能性があります。ヒトマイクロバイオームは、私たちの健康や生活全般において重要な役割を果たす存在であり、今後の研究が非常に楽しみです。 |
